Relapse after abrupt discontinuation of maintenance electroconvulsive therapy during the COVID-19 pandemic.
Simon LambrichtsKristof VansteelandtBo CrauwelsJasmien ObbelsEva PilatoJonas DenduyverKatrien ErnesPieter-Paul MaebeCharlotte MigchelsLore RoosenSatya BuggenhoutFilip BouckaertDidier SchrijversPascal SienaertPublished in: Acta psychiatrica Scandinavica (2021)
Almost half of the patients relapsed, similar to the relapse rate after a successful acute course of ECT. Patients with a shorter interval between M-ECT treatments at the time of discontinuation seem to be at increased risk, as well as patients with a diagnosis of psychotic disorder, compared to patients with mood disorders.
Keyphrases
- end stage renal disease
- bipolar disorder
- ejection fraction
- chronic kidney disease
- newly diagnosed
- acute lymphoblastic leukemia
- liver failure
- peritoneal dialysis
- prognostic factors
- free survival
- diffuse large b cell lymphoma
- intensive care unit
- multiple myeloma
- respiratory failure
- hepatitis b virus
- patient reported outcomes
- patient reported